Null effect of circulating sphingomyelins on risk for breast cancer: a Mendelian randomization report using Breast Cancer Association Consortium (BCAC) data
View ORCID ProfileCharleen D. Adams
doi: https://doi.org/10.1101/19013540
Charleen D. Adams
Beckman Research Institute
Data Availability
Data are publicly available via MR-Base and BCAC.
Posted December 04, 2019.
Null effect of circulating sphingomyelins on risk for breast cancer: a Mendelian randomization report using Breast Cancer Association Consortium (BCAC) data
Charleen D. Adams
medRxiv 19013540; doi: https://doi.org/10.1101/19013540
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)